Quidel | QDEL - Operating Profit


Quidel reported $-37.3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 443M 66M Sep/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
Illumina USD 256M 6M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Pacific Biosciences Of California USD -64.08M 111.77M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 270.52M 78.4M Dec/2025